SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001461993-20-000002
Filing Date
2020-04-14
Accepted
2020-04-14 17:27:26
Documents
3
Period of Report
2020-04-11
Items
Item 1.03: Bankruptcy or Receivership
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K-CONFIRMATION ORDER a8-kxconfirmationorder.htm 8-K 43801
2 EXHIBIT 99.1 ex991confirmationorderwith.htm EX-99.1 776179
3 EXHIBIT 99.2 ex992-morxmlntbsperiodendi.htm EX-99.2 53661
  Complete submission text file 0001461993-20-000002.txt   874947
Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35405 | Film No.: 20792024
SIC: 2834 Pharmaceutical Preparations